Diseases [C] » Infections [C01] » Bacterial Infections and Mycoses » Bacterial Infections » Gram-Positive Bacterial Infections » Clostridium Infections
Description
Infections with bacteria of the genus CLOSTRIDIUM and closely related CLOSTRIDIOIDES species. MeSH
Hierarchy View
Subtype Terms (5)
Botulism
8 drugs (4 approved, 4 experimental)
Enterocolitis, Pseudomembranous
11 drugs (7 approved, 4 experimental)
Gas Gangrene
3 drugs (2 approved, 1 experimental)
Tetanus
54 drugs (30 approved, 24 experimental)
Approved Indicated Drugs (2)
Phase 3 Indicated Drugs (13)
Phase 1 Indicated Drugs (10)
Other Experimental Indicated Drugs (9)
Organization Involved with Phase 4 Indications (35)
Organization Involved with Phase 3 Indications (31)
Organization Involved with Phase 2 Indications (79)
Bayfront Medical Center and Edward White Hospital
Catholic University of Sacred Heart, Rome
Central Indiana Gastroenterology Group
Centre de Sante et de Services Sociaux de Chicoutimi
Centre Hospitalier Regional de Trois-Rivieres
Chest, Infectious Diseases and Critical Care Assoc., PC
Department of Health and Human Services
Dr. Kiran C. Patel Research Institute
Finch Research and Development LLC.
Jersey Shore University Medical Center
MultiCare Health System Research Institute
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute on Aging (NIA)
Reading Hospital and Medical Center
Remington-Davis Clinical Research
Salient Pharmaceuticals Incorporated
Organization Involved with Phase 1 Indications (13)
Organization Involved with Other Experimental Indications (32)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
